Stat5 inhibitor, IST5-002, at nanomolar concentrations suppresses AR levels and PC growth in experimental PC models, including CRPC cells, CRPC tumors, and patient-derived PCs cultured ex vivo in tumor explant cultures. The gene discussed is STAT5A; the disease is neoplasm.